MAPT and Alzheimer disease: Evidence that astrocytes can specifically affect tau disease progression comes from astrocyte-specific ablation of ApoE4 (a GWAS-linked AD gene) in a P301S tau transgenic mouse model, which reduced neurodegeneration (Wang et al. 2021a).